Global Influenza Vaccine Market Research Report 2026(Status and Outlook)

May 2026 | 141 pages | ID: G2D69D11B58BEN
Bosson Research

Abstracts

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.Market Driver:The Influenza Vaccine market is driven by the rising global awareness of flu prevention and increasing government initiatives to promote vaccination programs. Seasonal influenza poses a significant public health burden, leading to hospitalizations and fatalities, particularly among high-risk populations such as the elderly, young children, and immunocompromised individuals. Governments and health organizations, including the WHO and CDC, actively support annual flu vaccination campaigns to reduce disease transmission. Additionally, advancements in vaccine technology, such as cell-based and recombinant influenza vaccines, are improving vaccine efficacy and production efficiency, further driving market growth.Market Challenge:Despite its importance, the Influenza Vaccine market faces challenges related to vaccine hesitancy, manufacturing constraints, and viral mutations. Public skepticism regarding vaccine safety and effectiveness, fueled by misinformation, hampers vaccination rates in some regions. Additionally, influenza viruses undergo frequent genetic mutations, requiring annual vaccine updates and posing challenges in predicting dominant strains. Manufacturing influenza vaccines is also time-sensitive, as traditional egg-based production methods have limitations in scalability and response speed during pandemics. These factors can impact supply chain stability and overall vaccine accessibility.Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 80%. North America is the largest market, has a share about 50%.

The global Influenza Vaccine market size was estimated at USD 9135.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Influenza Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Influenza Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Vaccine market.

Global Influenza Vaccine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Sanofi
• CSL
• GSK
• Viatris
• AstraZeneca
• Hualan Bio
• Changchun Institute of Biological
• Sinovac
• BCHT
• Jiangsu GDK
• KM Biologics

Market Segmentation (by Type)

• Trivalent Influenza Vaccine
• Quadrivalent Influenza Vaccine

Market Segmentation (by Application)

• 6 Months to 3 Years
• > 3 Years

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza Vaccine Market

Overview of the regional outlook of the Influenza Vaccine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Influenza Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Influenza Vaccine
1.2 Key Market Segments
  1.2.1 Influenza Vaccine Segment by Type
  1.2.2 Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INFLUENZA VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Influenza Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INFLUENZA VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Influenza Vaccine Product Life Cycle
3.3 Global Influenza Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Vaccine Market Competitive Situation and Trends
  3.8.1 Influenza Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Influenza Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 INFLUENZA VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Influenza Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Influenza Vaccine Market
5.7 ESG Ratings of Leading Companies

6 INFLUENZA VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Influenza Vaccine Market Size by Type (2020-2025)
6.4 Global Influenza Vaccine Price by Type (2020-2025)

7 INFLUENZA VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccine Market Sales by Application (2020-2025)
7.3 Global Influenza Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Vaccine Sales Growth Rate by Application (2020-2025)

8 INFLUENZA VACCINE MARKET SALES BY REGION

8.1 Global Influenza Vaccine Sales by Region
  8.1.1 Global Influenza Vaccine Sales by Region
  8.1.2 Global Influenza Vaccine Sales Market Share by Region
8.2 Global Influenza Vaccine Market Size by Region
  8.2.1 Global Influenza Vaccine Market Size by Region
  8.2.2 Global Influenza Vaccine Market Size by Region
8.3 North America
  8.3.1 North America Influenza Vaccine Sales by Country
  8.3.2 North America Influenza Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Influenza Vaccine Sales by Country
  8.4.2 Europe Influenza Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Influenza Vaccine Sales by Region
  8.5.2 Asia Pacific Influenza Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Influenza Vaccine Sales by Country
  8.6.2 South America Influenza Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Influenza Vaccine Sales by Region
  8.7.2 Middle East and Africa Influenza Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 INFLUENZA VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of Influenza Vaccine by Region(2020-2025)
9.2 Global Influenza Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Vaccine Production
  9.4.1 North America Influenza Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Vaccine Production
  9.5.1 Europe Influenza Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Vaccine Production (2020-2025)
  9.6.1 Japan Influenza Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Vaccine Production (2020-2025)
  9.7.1 China Influenza Vaccine Production Growth Rate (2020-2025)
  9.7.2 China Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Sanofi
  10.1.1 Sanofi Basic Information
  10.1.2 Sanofi Influenza Vaccine Product Overview
  10.1.3 Sanofi Influenza Vaccine Product Market Performance
  10.1.4 Sanofi Business Overview
  10.1.5 Sanofi SWOT Analysis
  10.1.6 Sanofi Recent Developments
10.2 CSL
  10.2.1 CSL Basic Information
  10.2.2 CSL Influenza Vaccine Product Overview
  10.2.3 CSL Influenza Vaccine Product Market Performance
  10.2.4 CSL Business Overview
  10.2.5 CSL SWOT Analysis
  10.2.6 CSL Recent Developments
10.3 GSK
  10.3.1 GSK Basic Information
  10.3.2 GSK Influenza Vaccine Product Overview
  10.3.3 GSK Influenza Vaccine Product Market Performance
  10.3.4 GSK Business Overview
  10.3.5 GSK SWOT Analysis
  10.3.6 GSK Recent Developments
10.4 Viatris
  10.4.1 Viatris Basic Information
  10.4.2 Viatris Influenza Vaccine Product Overview
  10.4.3 Viatris Influenza Vaccine Product Market Performance
  10.4.4 Viatris Business Overview
  10.4.5 Viatris Recent Developments
10.5 AstraZeneca
  10.5.1 AstraZeneca Basic Information
  10.5.2 AstraZeneca Influenza Vaccine Product Overview
  10.5.3 AstraZeneca Influenza Vaccine Product Market Performance
  10.5.4 AstraZeneca Business Overview
  10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
  10.6.1 Hualan Bio Basic Information
  10.6.2 Hualan Bio Influenza Vaccine Product Overview
  10.6.3 Hualan Bio Influenza Vaccine Product Market Performance
  10.6.4 Hualan Bio Business Overview
  10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
  10.7.1 Changchun Institute of Biological Basic Information
  10.7.2 Changchun Institute of Biological Influenza Vaccine Product Overview
  10.7.3 Changchun Institute of Biological Influenza Vaccine Product Market Performance
  10.7.4 Changchun Institute of Biological Business Overview
  10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
  10.8.1 Sinovac Basic Information
  10.8.2 Sinovac Influenza Vaccine Product Overview
  10.8.3 Sinovac Influenza Vaccine Product Market Performance
  10.8.4 Sinovac Business Overview
  10.8.5 Sinovac Recent Developments
10.9 BCHT
  10.9.1 BCHT Basic Information
  10.9.2 BCHT Influenza Vaccine Product Overview
  10.9.3 BCHT Influenza Vaccine Product Market Performance
  10.9.4 BCHT Business Overview
  10.9.5 BCHT Recent Developments
10.10 Jiangsu GDK
  10.10.1 Jiangsu GDK Basic Information
  10.10.2 Jiangsu GDK Influenza Vaccine Product Overview
  10.10.3 Jiangsu GDK Influenza Vaccine Product Market Performance
  10.10.4 Jiangsu GDK Business Overview
  10.10.5 Jiangsu GDK Recent Developments
10.11 KM Biologics
  10.11.1 KM Biologics Basic Information
  10.11.2 KM Biologics Influenza Vaccine Product Overview
  10.11.3 KM Biologics Influenza Vaccine Product Market Performance
  10.11.4 KM Biologics Business Overview
  10.11.5 KM Biologics Recent Developments

11 INFLUENZA VACCINE MARKET FORECAST BY REGION

11.1 Global Influenza Vaccine Market Size Forecast
11.2 Global Influenza Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Influenza Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific Influenza Vaccine Market Size Forecast by Region
  11.2.4 South America Influenza Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Influenza Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Influenza Vaccine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2026-2035)
  12.1.2 Global Influenza Vaccine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Influenza Vaccine by Type (2026-2035)
12.2 Global Influenza Vaccine Market Forecast by Application (2026-2035)
  12.2.1 Global Influenza Vaccine Sales (K MT) Forecast by Application
  12.2.2 Global Influenza Vaccine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Vaccine Market Size by Type (M USD)
Table 4. Global Influenza Vaccine Market Size by Application
Table 5. Influenza Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Influenza Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2025)
Table 11. Global Market Influenza Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza Vaccine Sales by Type (K MT)
Table 27. Global Influenza Vaccine Market Size by Type (M USD)
Table 28. Global Influenza Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Influenza Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza Vaccine Market Share by Type (2020-2025)
Table 32. Global Influenza Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Influenza Vaccine Sales (K MT) by Application
Table 34. Global Influenza Vaccine Market Size by Application
Table 35. Global Influenza Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Influenza Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza Vaccine Market Share by Application (2020-2025)
Table 39. Global Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza Vaccine Market Size by Region (2020-2025)
Table 44. North America Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Influenza Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Influenza Vaccine Product Overview
Table 64. Sanofi Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Influenza Vaccine Product Overview
Table 70. CSL Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Influenza Vaccine Product Overview
Table 76. GSK Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Influenza Vaccine Product Overview
Table 82. Viatris Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Influenza Vaccine Product Overview
Table 87. AstraZeneca Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Influenza Vaccine Product Overview
Table 92. Hualan Bio Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. Changchun Institute of Biological Basic Information
Table 96. Changchun Institute of Biological Influenza Vaccine Product Overview
Table 97. Changchun Institute of Biological Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Changchun Institute of Biological Business Overview
Table 99. Changchun Institute of Biological Recent Developments
Table 100. Sinovac Basic Information
Table 101. Sinovac Influenza Vaccine Product Overview
Table 102. Sinovac Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinovac Business Overview
Table 104. Sinovac Recent Developments
Table 105. BCHT Basic Information
Table 106. BCHT Influenza Vaccine Product Overview
Table 107. BCHT Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. BCHT Business Overview
Table 109. BCHT Recent Developments
Table 110. Jiangsu GDK Basic Information
Table 111. Jiangsu GDK Influenza Vaccine Product Overview
Table 112. Jiangsu GDK Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jiangsu GDK Business Overview
Table 114. Jiangsu GDK Recent Developments
Table 115. KM Biologics Basic Information
Table 116. KM Biologics Influenza Vaccine Product Overview
Table 117. KM Biologics Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. KM Biologics Business Overview
Table 119. KM Biologics Recent Developments
Table 120. Global Influenza Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Influenza Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Influenza Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Influenza Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Influenza Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Influenza Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Influenza Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Influenza Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Influenza Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Influenza Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Influenza Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Influenza Vaccine Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Influenza Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Influenza Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Vaccine Product Life Cycle
Figure 13. Influenza Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Influenza Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Influenza Vaccine
Figure 19. Global Influenza Vaccine Market PEST Analysis
Figure 20. Global Influenza Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Vaccine Market Share by Type
Figure 27. Sales Market Share of Influenza Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Vaccine by Type in 2025
Figure 29. Market Share of Influenza Vaccine by Type (2020-2025)
Figure 30. Market Share of Influenza Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Vaccine Market Share by Application
Figure 33. Global Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Vaccine Sales Market Share by Application in 2025
Figure 35. Global Influenza Vaccine Market Share by Application (2020-2025)
Figure 36. Global Influenza Vaccine Market Share by Application in 2025
Figure 37. Global Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Vaccine Market Size by Region (2020-2025)
Figure 40. North America Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Vaccine Sales Market Share by Country in 2024
Figure 43. North America Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Vaccine Market Size by Country in 2024
Figure 45. U.S. Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Vaccine Market Size by Country in 2024
Figure 55. Germany Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Vaccine Market Size by Region in 2024
Figure 68. China Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Influenza Vaccine Sales Market Share by Country in 2024
Figure 80. South America Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Vaccine Market Size by Country in 2024
Figure 82. Brazil Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Influenza Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza Vaccine Market Share Forecast by Application (2026-2035)